Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.
NCT ID: NCT02197611
Last Updated: 2015-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2015-09-30
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Multidisciplinary Evaluation of Patients With Hemophilia
NCT02198430
Adherence to Treatment in Hemophilia
NCT02191436
Transcultural Multidisciplinary Evaluation of Patients With Hemophili
NCT02199639
Pain and Joint Status With Psychosocial Factors in Patients With Hemophilia
NCT04715100
Validation of a Specific Measure for Assessment of Compliance With Treatment in Patients With Hemophilia
NCT02582450
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Validation of a scale specific measure for patients with hemophilia that includes 5 dimensions that may affect adherence to treatment: a) the doctor-patient, b) regarding knowledge of the disease, c) the previous hemorrhages, d) knowledge future sequels, e) difficulties with treatment.
* Statistical and psychometric analysis of the adherence questionnaire for adult patients with hemophilia.
* Description of the theoretical framework that justifies the completion of the questionnaire, and the choice of the dimensions and items that make up the measurement scale.
* The questionnaire obtained in this project will identify the actual degree of patient adherence to multidisciplinary treatment, taking as gold standard, compliance with pharmacological treatment (the difference between the treatment prescribed and consumed).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Validation group
Group of patients who we will consult the characteristics of the scale designed and will be made the statistical calculations of validity, reliability and reproducibility
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients over 18 years of age.
Exclusion Criteria
* Patients who have not signed the informed consent document
18 Years
65 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Murcia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ANA TORRES-ORTUÑO
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rubén Cuesta-Barriuso, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidad Católica San Antonio
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad de Murcia
Murcia, Murcia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Haemo-Adhaesione
Identifier Type: OTHER
Identifier Source: secondary_id
Haemo Adhaesione
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.